iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 5 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

1
Player Avatar yijo (91.10) Submitted: 6/28/2007 10:43:09 AM : Outperform Start Price: $4.12 ICAD Score: -80.76

Great potential.

Report this Post 1 Comment
Member Avatar AlcoveNooses (89.87) Submitted: 4/4/2009 11:12:42 PM
Recs: 0

ICAD has quite an impressive balance sheet and is quite undervalued as it is now below a dollar , considering that it has a market for its product.

Featured Broker Partners


Advertisement